Generic and Specialty Pharmaceuticals (TRBC)

Israel`s Gamida Cell raises $40 million for bone marrow trial

Israel`s Gamida Cell raises $40 million for bone marrow trial

Published 19/06/2017

Israel's Gamida Cell, which is developing cellular therapies to treat cancer and rare genetic diseases, said on Monday it raised $40 million to finance the advanced trial of its product NiCord to facilitate bone marrow transplants.

[more…]

Novartis wins European approval for biosimilar version of Roche`s MabThera

Novartis wins European approval for biosimilar version of Roche`s MabThera

Published 19/06/2017

Swiss drugmaker Novartis on Monday said it had won European approval for its biosimilar version of Roche's blockbuster Rituxan as the crosstown rivals go head-to-head on a drug to treat blood cancers and immunological diseases.

[more…]

New test may turn AZ`s Lynparza into precision drug for prostate cancer

New test may turn AZ`s Lynparza into precision drug for prostate cancer

Published 18/06/2017

FILE PHOTO: The logo of AstraZeneca is seen on a medication package in a pharmacy in London, Britain, April 28, 2014. REUTERS/Stefan Wermuth/File Photo

Scientists have developed a new three-in-one blood test that has the potential to turn AstraZeneca's drug Lynparza into a precision medicine for prostate cancer.

[more…]

Sanofi chief says U.S. Supreme Court ruling on biologics has “immediate impact”

Sanofi chief says U.S. Supreme Court ruling on biologics has “immediate impact”

Published 16/06/2017

FILE PHOTO - French multinational pharmaceutical company SANOFI logo seen at their headquaters in Paris, France, March 8, 2016. REUTERS/Philippe Wojazer/File Photo

The U.S Supreme Court decision to speed access to copycat biologics drugs on Monday was expected but has an "immediate impact", Sanofi Chief Executive told Reuters.

[more…]

Centrexion`s chili-based painkiller offers relief for 6 months – study

Centrexion`s chili-based painkiller offers relief for 6 months – study

Published 13/06/2017

A synthetic version of a medicine traditionally extracted from chili plant relieved knee pain among osteoarthritis patients for up to six months, data showed, bringing Centrexion Therapeutics a step closer to developing a safe and effective analgesic.

[more…]

Aspirin linked to higher risk of serious bleeding in the elderly

Aspirin linked to higher risk of serious bleeding in the elderly

Published 13/06/2017

People who are aged 75 or older and take aspirin daily to ward off heart attacks face a significantly elevated risk of serious or even fatal bleeding and should be given heartburn drugs to minimize the danger, a 10-year study has found.

[more…]

Sanofi-Regeneron`s Praluent cuts cholesterol in Odyssey trials

Sanofi-Regeneron`s Praluent cuts cholesterol in Odyssey trials

Published 11/06/2017

France's Sanofi and partner Regeneron Pharmaceuticals said on Sunday their anti-cholesterol drug Praluent recorded positive results in its first dedicated studies involving patients with diabetes and high cholesterol.

[more…]

Roche CEO still optimistic on new breast cancer drug

Roche CEO still optimistic on new breast cancer drug

Published 11/06/2017

Swiss drugmaker Roche's logo is seen at their headquarters in Basel, Switzerland January 28, 2016. REUTERS/Arnd Wiegmann

Roche is convinced a new breast cancer drug will have a significant role in treating the disease despite recent trial results that disappointed analysts, the Swiss drugmaker's chief executive said in an interview published on Sunday.

[more…]

AbbVie must pay $15 million in Depakote birth-defect trial: jury

AbbVie must pay $15 million in Depakote birth-defect trial: jury

Published 09/06/2017

FILE PHOTO -- A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange July 18, 2014. REUTERS/Brendan McDermid/File Photo

A federal jury on Friday awarded $15 million to a 10-year-old boy whose mother blamed his birth defect on AbbVie Inc's (ABBV.N) bipolar disorder drug Depakote that she took while pregnant, in the latest trial among hundreds of lawsuits over the product.

[more…]

In major breakthrough, tiny Utah firm regenerates skin, hair in pigs

In major breakthrough, tiny Utah firm regenerates skin, hair in pigs

Published 08/06/2017

A small U.S. biotech has successfully regenerated skin and stimulated hair growth in pigs with burns and abrasions, paving the way for a scientific breakthrough that could lead to the regeneration of fully functional human skin.

[more…]